StemCell Institute Inc. (TYO:7096)

Japan flag Japan · Delayed Price · Currency is JPY
844.00
-11.00 (-1.29%)
At close: Feb 6, 2026
-44.73%
Market Cap8.65B -36.8%
Revenue (ttm)2.72B +3.0%
Net Income198.00M -53.1%
EPS19.45 -52.8%
Shares Out10.25M
PE Ratio43.40
Forward PE53.08
Dividendn/a
Ex-Dividend Daten/a
Volume11,600
Average Volume14,475
Open850.00
Previous Close855.00
Day's Range835.00 - 855.00
52-Week Range744.00 - 1,543.00
Beta0.54
RSI57.61
Earnings DateFeb 12, 2026

About StemCell Institute

StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of new cell-based treatments, and pharmaceuticals and medical devices. It also engages in cell contract management and transportation business; extraction, purification, processing, storage, testing and sales of biological tissue-derived components; and medical facility operation and management business. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 117
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 7096
Full Company Profile

Financial Performance

In fiscal year 2025, StemCell Institute's revenue was 2.68 billion, an increase of 7.98% compared to the previous year's 2.48 billion. Earnings were 385.00 million, an increase of 24.19%.

Financial Statements